You are here: Home » News-CM » Companies » Results
Business Standard

Sun Pharmaceuticals Industries reports consolidated net profit of Rs 1064.09 crore in the September 2019 quarter

Capital Market 

Sales rise 16.11% to Rs 7949.19 crore

Net profit of Sun Pharmaceuticals Industries reported to Rs 1064.09 crore in the quarter ended September 2019 as against net loss of Rs 269.60 crore during the previous quarter ended September 2018. Sales rose 16.11% to Rs 7949.19 crore in the quarter ended September 2019 as against Rs 6846.48 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales7949.196846.48 16 OPM %22.5122.36 -PBDT1906.661752.83 9 PBT1433.381326.32 8 NP1064.09-269.60 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, November 07 2019. 17:13 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU